CClinicalTrials.gg
RecruitingNCT06310278Updated Aug 1, 2024

Ossiview Normative Mobility Data Collection Protocol

An observational study in Conductive Hearing Loss, Middle Ear, sponsored by Audioptics Medical Incorporated. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-01.

Sponsored by Audioptics Medical Incorporated · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn about the sound-induced vibration level of certain structures in the middle ear in the normal-hearing population. The targeted structures are part of a chain of structures responsible for conducting sound within the auditory system and so their ability to vibrate normally in response to sound is relevant to the diagnosis of conductive hearing loss.

The main questions the study aims to answer are:

  • What are the mean and variance of the normal sound-induced vibration level at two anatomical locations, the umbo of the malleus and the tip of the incus?
  • Are there any significant differences in these vibrational responses associated with sex or age?

Participants will have their ossicular mobility measured with an investigational medical device that sends light into the middle ear and measures the motion-induced phase shift on light reflected from the target structures when a sound stimulus is presented. Standard hearing tests including audiometry and tympanometry will also be performed to confirm the normal hearing status of participants.

02

Conditions studied

  • Conductive Hearing Loss, Middle Ear

Keywords

  • optical coherence tomography
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Minimum 120 normal-hearing subjects including at least 10 male and 10 female subjects in each age group 18-30, 30-40, 40-50, 50-60 and 60+

Inclusion criteria

  • Normal-hearing
  • Over the age of 18
  • At least one of incus or umbo visible under otoscopic examination
  • Type A 226Hz tympanogram with peak static compliance occurring at pressure between -99mmH20 and +50mmH20 and peak static compliance in the range from 0.3 to 1.6 cc

Exclusion criteria

Exclusion Criteria:

  • Audiometric air conduction thresholds greater than 40 dBHL at 500 Hz, 750 Hz, 1000 Hz, 1500Hz, 2000 Hz, 3000 Hz
  • Audiometric air bone gap greater than 5dB at 500Hz, 750Hz, 1000Hz, 1500Hz, 2000Hz and 3000Hz
  • Self-reported history of ear infection in the previous 3 months
  • Self-reported history of middle ear surgery in the last 5 years
  • Self-reported history of tympanic membrane perforation within the last 5 years
  • Self-reported medical treatment for any ear-related disorder within the last 5 years
  • Evidence of perforation, tympanosclerosis, otitis externa, thickened or fibrotic eardrum, mycosis, fluid, infection or other ear abnormality under otoscopy
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Normal-hearing

    Diagnostic Test: Ossicular mobility measurement

Interventions

  • Diagnostic testOssicular mobility measurement

    Measurements of ossicular mobility i.e. the dynamic velocity of middle ear structures (umbo of malleus and incus at the incudostapedial joint) normalized to sound pressure incident on the tympanic membrane.

05

What researchers measure

Primary outcomes

  1. Umbo mobility

    Estimated mean and variance of mobility in mm/s/Pa in the normal-hearing population measured at the umbo of the malleus at 500Hz, 750Hz, 1000Hz, 1500Hz, 2000Hz and 3000Hz stimulus frequencies.

    Time frame: At study completion (6 months)

  2. Incus mobility

    Estimated mean and variance of mobility in mm/s/Pa in the normal-hearing population measured at the incus lateral to the incudostapedial joint at 500Hz, 750Hz, 1000Hz, 1500Hz, 2000Hz and 3000Hz stimulus frequencies.

    Time frame: At study completion (6 months)

Secondary outcomes

  1. Dependence on age and sex

    p-values for dependence on age, sex and age-sex interaction at each stimulus frequency within two-way ANOVA.

    Time frame: At study completion (6 months)

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06310278
Lead sponsor
Audioptics Medical Incorporated
Responsible party
Sponsor
First posted
Mar 15, 2024
Start date
May 9, 2024
Primary completion
Oct 31, 2024 (estimated)
Completion
Oct 31, 2024 (estimated)
Last update
Aug 1, 2024

Study contacts

Robert Adamson, PhD
Contact
rob.adamson@audiopticsmedical.com
902-497-8579
Cathy Creaser, MSc
Contact
cathy.creaser@audiopticsmedical.com
David P Morris, FRCS(Oto)
principal investigator · Nova Scotia Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion